{"id":26637,"date":"2021-07-08T10:58:45","date_gmt":"2021-07-08T07:58:45","guid":{"rendered":"https:\/\/aluksne.lv\/?p=26637"},"modified":"2021-07-08T11:02:44","modified_gmt":"2021-07-08T08:02:44","slug":"uzzini-par-vakcinu-izstradi-darbibu-intervalu-starp-devam-un-biezakajam-blakusparadibam-atjauninats-informativs-materials-latviesu-un-krievu-valoda","status":"publish","type":"post","link":"https:\/\/aluksne.lv\/index.php\/2021\/07\/08\/uzzini-par-vakcinu-izstradi-darbibu-intervalu-starp-devam-un-biezakajam-blakusparadibam-atjauninats-informativs-materials-latviesu-un-krievu-valoda\/","title":{"rendered":"Uzzini par vakc\u012bnu izstr\u0101di, darb\u012bbu, interv\u0101lu starp dev\u0101m un bie\u017e\u0101kaj\u0101m blakuspar\u0101d\u012bb\u0101m: atjaunin\u0101ts informat\u012bvs materi\u0101ls latvie\u0161u un krievu valod\u0101"},"content":{"rendered":"<p><strong>Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA) atjaunin\u0101jusi informat\u012bvu materi\u0101lu par vakc\u012bn\u0101m pret Covid-19 latvie\u0161u valod\u0101, k\u0101 ar\u012b no jauna izstr\u0101d\u0101jusi \u0161o materi\u0101lu krievu valod\u0101. Materi\u0101ls satur pier\u0101d\u012bjumos balst\u012btu un uzticamu inform\u0101ciju par l\u012bdz \u0161im lieto\u0161anai apstiprin\u0101to Covid-19 vakc\u012bnu darb\u012bbu un b\u016btisk\u0101kaj\u0101m blakuspar\u0101d\u012bb\u0101m.<\/strong><\/p>\n<p>Informat\u012bvaj\u0101 materi\u0101l\u0101 ietverta ar\u012b svar\u012bg\u0101k\u0101 inform\u0101cija par vakc\u012bnu izstr\u0101di un apstiprin\u0101\u0161anu, laika interv\u0101lu starp vakc\u012bnas pirmo un otro devu un cita inform\u0101cija.<\/p>\n<p>Informat\u012bvais materi\u0101ls ikvienam pieejams elektroniski ZVA t\u012bmek\u013cvietnes www.zva.gov.lv sada\u013c\u0101 \u201c<a href=\"https:\/\/www.zva.gov.lv\/lv\/covid-19-zinas\">Covid-19 zi\u0146as<\/a>\u201d.<\/p>\n<p>ZVA atg\u0101dina, ka vakc\u012bnu m\u0113r\u0137is ir nov\u0113rst saslim\u0161anu ar koronav\u012brusu, tai skait\u0101 pasarg\u0101t no simptom\u0101tiskas saslim\u0161anas, smagas Covid-19 slim\u012bbas gaitas, hospitaliz\u0101cijas un n\u0101ves.<\/p>\n<p>L\u012bdz \u0161im Eirop\u0101, tai skait\u0101 Latvij\u0101, lieto\u0161anai apstiprin\u0101tas \u010detras Covid-19 vakc\u012bnas.<\/p>\n<p>Lai ieg\u016btu piln\u012bgu un notur\u012bgu aizsardz\u012bbu pret koronav\u012brusu, nepiecie\u0161amas divas Pfizer-BioNTech (\u201cComirnaty\u201d), Moderna (\u201cSpikevax\u201d), AstraZeneca (\u201cVaxzevria\u201d) izstr\u0101d\u0101t\u0101s vakc\u012bnas devas, vai viena deva \u2013 Janssen vakc\u012bnas gad\u012bjum\u0101.<\/p>\n<p>ZVA v\u0113r\u0161 uzman\u012bbu, ka aizsardz\u012bba var neb\u016bt piln\u012bga l\u012bdz 7 dien\u0101m p\u0113c Pfizer-BioNTech, l\u012bdz 14 dien\u0101m p\u0113c Moderna un l\u012bdz 15 dien\u0101m p\u0113c AstraZaneca vakc\u012bnas otr\u0101s devas sa\u0146em\u0161anas.<\/p>\n<p>Janssen Covid-19 vakc\u012bnas lieto\u0161anas gad\u012bjum\u0101 nepiecie\u0161ama viena deva un piln\u012bga aizsardz\u012bba iest\u0101jas 14 dienas p\u0113c t\u0101s sa\u0146em\u0161anas.<\/p>\n<p>Otr\u0101 Pfizer-BioNTech vai Moderna izstr\u0101d\u0101t\u0101s vakc\u012bnas deva j\u0101sa\u0146em vismaz 3 l\u012bdz 4 ned\u0113\u013cas p\u0113c pirm\u0101s devas. Savuk\u0101rt AstraZeneca vakc\u012bnai otr\u0101s devas rekomend\u0113tais interv\u0101ls ir 9-12 ned\u0113\u013cas, vakcin\u0101cijas rokasgr\u0101mat\u0101 nor\u0101d\u012bts, ka \u0161\u012bs vakc\u012bnas otr\u0101s devas sa\u0146em\u0161anas viz\u012bte pl\u0101nojama tuv\u0101k 12. ned\u0113\u013cai.<\/p>\n<p>Vakc\u012bna tiek ievad\u012bta cilv\u0113ka aug\u0161delm\u0101.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p><strong>K\u0101 vakc\u012bnas tika apstiprin\u0101tas?<\/strong><\/p>\n<p>Vakc\u012bnas tika izstr\u0101d\u0101tas un apstiprin\u0101tas pa\u0101trin\u0101t\u0101 k\u0101rt\u012bb\u0101. Tas bija iesp\u0113jams, jo eksperti vis\u0101 pasaul\u0113 sadarboj\u0101s, lai atkl\u0101tu vakc\u012bnu. Notika \u0101tra apmain\u012b\u0161an\u0101s ar b\u016btisku inform\u0101ciju. Vienlaikus tika veikti vair\u0101ki p\u0113t\u012bjumi par vakc\u012bnas dro\u0161umu un efektivit\u0101ti. T\u0101d\u0113j\u0101di tika ietaup\u012bts daudz laika. \u0160ie p\u0113t\u012bjumi tika izv\u0113rt\u0113ti, tikl\u012bdz bija zin\u0101mi to rezult\u0101ti.<\/p>\n<ul>\n<li>T\u0101d\u0113j\u0101di bija iesp\u0113jams \u0161\u012bs vakc\u012bnas izstr\u0101d\u0101t un apstiprin\u0101t \u0101tr\u0101k nek\u0101 parasti, neizlai\u017eot b\u016btiskus procesa so\u013cus. Vakc\u012bnas apstiprin\u0101jusi Eiropas Z\u0101\u013cu a\u0123ent\u016bra, kuras zin\u0101tnisk\u0101s komitej\u0101s piedal\u0101s ar\u012b ZVA speci\u0101listi.<\/li>\n<\/ul>\n<p><strong>Bie\u017e\u0101k\u0101s blakuspar\u0101d\u012bbas<\/strong><\/p>\n<p>ZVA atg\u0101dina, ka l\u012bdz\u012bgi k\u0101 p\u0113c citu vakc\u012bnu sa\u0146em\u0161anas, ar\u012b p\u0113c Covid-19 vakc\u012bnu sa\u0146em\u0161anas var rasties blakuspar\u0101d\u012bbas. Vairums blakuspar\u0101d\u012bbu rodas, jo vakc\u012bnas stimul\u0113 cilv\u0113ka organisma im\u016bnsist\u0113mu.<\/p>\n<p>T\u0101 rezult\u0101t\u0101 da\u013cai cilv\u0113ku vi\u0146u organisma \u012bpatn\u012bbas d\u0113\u013c var rasties sagaid\u0101mas reakcijas jeb blakuspar\u0101d\u012bbas. Tom\u0113r \u0161\u0101du reakciju ra\u0161an\u0101s vai tr\u016bkums neliecina par to, cik stipra vakcin\u0101cijas rezult\u0101t\u0101 b\u016bs ieg\u016bt\u0101 organisma aizsardz\u012bba.<\/p>\n<p>P\u0113t\u012bjumi liecina, ka bie\u017e\u0101k\u0101s blakuspar\u0101d\u012bbas ietver paaugstin\u0101tu \u0137erme\u0146a temperat\u016bru (da\u017ek\u0101rt virs 38\u00b0C), drudzi, galvass\u0101pes, nogurumu, s\u0101pes injekcijas viet\u0101, musku\u013cu un loc\u012btavu s\u0101pes, aps\u0101rtumu, piet\u016bkumu injekcijas viet\u0101. \u0160\u012bs blakuspar\u0101d\u012bbas parasti ilgst 1 l\u012bdz 3 dienas un p\u0113c tam izz\u016bd.<\/p>\n<p>Pacientiem j\u0101v\u0113r\u0161as pie \u0101rsta, ja p\u0113c vakc\u012bnas sa\u0146em\u0161anas rodas ba\u017eas par nov\u0113rotaj\u0101m blakuspar\u0101d\u012bb\u0101m. Gan \u0101rsts vai farmaceits, gan pacients var zi\u0146ot par konstat\u0113t\u0101m z\u0101\u013cu, to vid\u016b ar\u012b vakc\u012bnu, izrais\u012bt\u0101m blakuspar\u0101d\u012bb\u0101m Z\u0101\u013cu valsts a\u0123ent\u016brai. Zi\u0146ojumu var iesniegt ar\u012b elektroniski Z\u0101\u013cu valsts a\u0123ent\u016bras t\u012bmek\u013cvietn\u0113 www.zva.gov.lv &gt; <a href=\"https:\/\/www.zva.gov.lv\/lv\/zinot-par-zalu-blaknem-negadijumiem-ar-iericem-biovigilanci\" target=\"_blank\" rel=\"noopener\">\u201cZi\u0146ot par z\u0101\u013cu blakn\u0113m, negad\u012bjumiem ar ier\u012bc\u0113m un biovigilanci\u201d<\/a>.<\/p>\n<p>ZVA uzsver, ka visas ES apstiprin\u0101t\u0101s vakc\u012bnas ir p\u0101rbaud\u012btas un dro\u0161as lieto\u0161anai.<\/p>\n<p><strong>Vai dr\u012bkstu sa\u0146emt vakc\u012bnu? B\u016btisk\u0101kie br\u012bdin\u0101jumi<\/strong><\/p>\n<p>Informat\u012bvaj\u0101 materi\u0101l\u0101 ietverta svar\u012bg\u0101k\u0101 inform\u0101cija, kad pirms vakcin\u0101cijas veik\u0161anas b\u016btu j\u0101konsult\u0113jas ar \u0101rstu.<\/p>\n<p>Proti, cilv\u0113kam j\u0101jaut\u0101 savam \u0123imenes \u0101rstam, vai dr\u012bkst sa\u0146emt \u0161\u012bs vakc\u012bnas, ja iepriek\u0161 p\u0113c cita veida vakc\u012bnas sa\u0146em\u0161anas ir bijusi aler\u0123iska reakcija vai ir bijusi aler\u0123iska reakcija p\u0113c pirm\u0101s vakcin\u0101cijas ar \u0161\u012bm Covid-19 vakc\u012bn\u0101m.<\/p>\n<p>Pirms vakcin\u0101cijas nepiecie\u0161ams konsult\u0113ties ar speci\u0101listu, kur\u0161 izv\u0113rt\u0113s vai dr\u012bkstat vakcin\u0113ties. Pirms vakcin\u0113\u0161an\u0101s nepiecie\u0161ams oblig\u0101ti inform\u0113t \u0101rstu, ja tiek nov\u0113rota smaga saslim\u0161ana, drudzis, Covid-19 rakstur\u012bgi simptomi, ir apstiprin\u0101ta saslim\u0161ana ar Covid-19, ir j\u0101iev\u0113ro pa\u0161izol\u0101cija vai karant\u012bna p\u0113c kontakt\u0113\u0161an\u0101s ar cilv\u0113ku, kam ir Covid-19, vai tas gaida testa rezult\u0101tus, k\u0101 ar\u012b ja ir nokav\u0113ta vakcin\u0101cijas viz\u012bte.<\/p>\n<p>Informat\u012bvaj\u0101 materi\u0101l\u0101 nor\u0101d\u012bta visu re\u0123istr\u0113to vakc\u012bnu inform\u0101cija, ta\u010du t\u0101 neaizst\u0101j ofici\u0101lo z\u0101\u013cu lieto\u0161anas instrukciju, kas ikvienam pieejama <a href=\"https:\/\/www.zva.gov.lv\/zvais\/zalu-registrs\/?lang=lv\" target=\"_blank\" rel=\"noopener\">Z\u0101\u013cu re\u0123istr\u0101<\/a>, un \u0101rsta sniegtos nor\u0101d\u012bjumus.<\/p>\n<p><a href=\"https:\/\/aluksne.lv\/wp-content\/uploads\/2021\/07\/Vakcinu-infobuklets_LV-1.pdf\">Buklets latvie\u0161u valod\u0101<\/a><\/p>\n<p><a href=\"https:\/\/aluksne.lv\/wp-content\/uploads\/2021\/07\/Vakcinu-infobuklets_RUS.pdf\">Buklets krievu valod\u0101<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA) atjaunin\u0101jusi informat\u012bvu materi\u0101lu par vakc\u012bn\u0101m pret Covid-19 latvie\u0161u valod\u0101, k\u0101 ar\u012b no jauna izstr\u0101d\u0101jusi \u0161o materi\u0101lu krievu valod\u0101. Materi\u0101ls satur pier\u0101d\u012bjumos balst\u012btu un uzticamu inform\u0101ciju par l\u012bdz \u0161im lieto\u0161anai apstiprin\u0101to Covid-19 vakc\u012bnu darb\u012bbu un b\u016btisk\u0101kaj\u0101m blakuspar\u0101d\u012bb\u0101m&#8230;.<br \/><a class=\"read-more-button\" href=\"https:\/\/aluksne.lv\/index.php\/2021\/07\/08\/uzzini-par-vakcinu-izstradi-darbibu-intervalu-starp-devam-un-biezakajam-blakusparadibam-atjauninats-informativs-materials-latviesu-un-krievu-valoda\/\">Las\u012bt visu<\/a><\/p>\n","protected":false},"author":1,"featured_media":26643,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[9],"tags":[],"class_list":["post-26637","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noderiga-informacija"],"_links":{"self":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/26637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/comments?post=26637"}],"version-history":[{"count":0,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/26637\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/media\/26643"}],"wp:attachment":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/media?parent=26637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/categories?post=26637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/tags?post=26637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}